Amneal Pharmaceuticals (AMRX) Leases: 2019-2025
Historic Leases for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Sep 2025 value amounting to $54.4 million.
- Amneal Pharmaceuticals' Leases fell 5.41% to $54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.4 million, marking a year-over-year decrease of 5.41%. This contributed to the annual value of $56.4 million for FY2024, which is 30.38% up from last year.
- As of Q3 2025, Amneal Pharmaceuticals' Leases stood at $54.4 million, which was down 1.18% from $55.1 million recorded in Q2 2025.
- In the past 5 years, Amneal Pharmaceuticals' Leases ranged from a high of $67.5 million in Q1 2021 and a low of $43.3 million during Q4 2023.
- Moreover, its 3-year median value for Leases was $57.5 million (2024), whereas its average is $56.8 million.
- Per our database at Business Quant, Amneal Pharmaceuticals' Leases declined by 22.88% in 2023 and then spiked by 30.38% in 2024.
- Amneal Pharmaceuticals' Leases (Quarterly) stood at $60.4 million in 2021, then declined by 7.04% to $56.1 million in 2022, then decreased by 22.88% to $43.3 million in 2023, then surged by 30.38% to $56.4 million in 2024, then decreased by 5.41% to $54.4 million in 2025.
- Its last three reported values are $54.4 million in Q3 2025, $55.1 million for Q2 2025, and $56.0 million during Q1 2025.